- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Lilly's sola study did not reduce amyloid plaques in the brain, adding to the likelihood that Biogen's late-stage Alzheimer's will prove successful.
Stocks move higher on Friday, trading at records, as the health care sector makes a comeback after a bruising week.
Stock futures move slightly higher on Friday, setting Wall Street to open at record highs after Thursday's session continued the markets' winning streak.
Here are Friday's top research calls, including upgrades for Autodesk and AstraZeneca, and downgrades for Aflac and Duluth.